Quarterly report · Q1
4078.TEDINET S100OUSM
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.4bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥80.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥19.6bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥2.1bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥8.8bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.6bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.4bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥1.7bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥127.2bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥123.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥123.6bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥43.2bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥41.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥84.0bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥82.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥80.4bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.5bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥109.4 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥407.06 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥97.22 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 62.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.2% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥435m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥435m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥558m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥19.8bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥19.5bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥360m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥74m |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥89m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥21.8bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥21.4bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥435m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥2.4bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥449m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥449m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | −¥521m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥18.1bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥17.7bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥385m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥2.6bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥63m |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥27m |
| —segment total | revenue | 2021-04-01 → 2021-06-30 | ¥20.0bn |
| —segment total | revenue external | 2021-04-01 → 2021-06-30 | ¥19.6bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥449m |
| —segment total | segment profit | 2021-04-01 → 2021-06-30 | ¥2.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 363
| Item | Context | Value | Unit |
|---|---|---|---|
| Noncurrent assets | Prior1YearInstant | 58423000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 57685000000 | JPY |
| Assets | Prior1YearInstant | 123919000000 | JPY |
| Assets | CurrentQuarterInstant | 127230000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 9452000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 10663000000 | JPY |
| Short term loans payable | Prior1YearInstant | 8202000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 10643000000 | JPY |
| Income taxes payable | Prior1YearInstant | 1771000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 691000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 1371000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 1767000000 | JPY |
| Other provision cl | Prior1YearInstant | 137000000 | JPY |
| Other provision cl | CurrentQuarterInstant | 42000000 | JPY |
| Other cl | Prior1YearInstant | 5836000000 | JPY |
| Other cl | CurrentQuarterInstant | 5504000000 | JPY |
| Current liabilities | Prior1YearInstant | 26771000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 29312000000 | JPY |
| Long term loans payable | Prior1YearInstant | 8756000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 8236000000 | JPY |
| Provision for environmental measures ncl | Prior1YearInstant | 139000000 | JPY |
| Provision for environmental measures ncl | CurrentQuarterInstant | 140000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 5190000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 5157000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 76000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 118000000 | JPY |
| Other ncl | Prior1YearInstant | 277000000 | JPY |
| Other ncl | CurrentQuarterInstant | 236000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 14439000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 13889000000 | JPY |
| Liabilities | Prior1YearInstant | 41211000000 | JPY |
| Liabilities | CurrentQuarterInstant | 43202000000 | JPY |
| Capital stock | Prior1YearInstant | 21838000000 | JPY |
| Capital stock | CurrentQuarterInstant | 21838000000 | JPY |
| Capital surplus | Prior1YearInstant | 16299000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 16299000000 | JPY |
| Retained earnings | Prior1YearInstant | 41433000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 42636000000 | JPY |
| Treasury stock | Prior1YearInstant | -1798000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -1799000000 | JPY |
| Shareholders equity | Prior1YearInstant | 77772000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 78975000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 1202000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 936000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 6000000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | 43000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -149000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 87000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 21000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 21000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |